ClinicalTrials.Veeva

Menu

Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.

M

Melbourne Health

Status and phase

Completed
Phase 4

Conditions

Atrial Fibrillation

Treatments

Drug: Fish oil

Study type

Interventional

Funder types

Other

Identifiers

NCT00232245
2003.216

Details and patient eligibility

About

The purpose of this study is to investigate whether fish oil supplements may reduce the frequency and duration of paroxysmal atrial fibrillation episodes.

Atrial fibrillation is a heart condition which effects a large percentage of the population .

Atrial fibrillation is a condition frequently experienced by people who have had pacemakers inserted .

Certain Pacemakers have sophisticated monitoring features that are able to recognise episodes of atrial fibrillation.

Fish oil supplements may be of benefit to patients with heart problems.Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

By interrogating pacemakers this study will investigate the effect of fish oil supplements on the frequency and duration of episodes of atrial fibrillation.

Enrollment

80 patients

Sex

All

Ages

18 to 88 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients who have had at least 2 previous episodes of atrial fibrillation and an implanted pacemaker.

Exclusion criteria

  • Patients with chronic atrial fibrillation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Fish oil
Experimental group
Description:
Patients prescribed 6g/day of fish oil containing total 1.8 g of EPA+DHA in a 1.5:1 ratio
Treatment:
Drug: Fish oil
Control
No Intervention group
Description:
No fish oil exposure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems